Company Profile
Treace Medical Concepts Stock Price, News & Analysis
- Ticker:
- TMCI
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Treace Medical Concepts is followed within the medical devices universe for its exposure to procedure trends and reimbursement support.
Stock performance
4.49 USD (+11.97%)
Close
Last updated: June 23, 2026 at 00:00
291.28M USD
Market cap
Why the stock is moving
TMCI is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Treace Medical Concepts is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Treace Medical Concepts is followed within the medical devices universe for its exposure to procedure trends and reimbursement support.
Business Model Characteristics
Treace Medical Concepts makes its case through product adoption, operating discipline, and the pace at which the installed base turns into recurring revenue.
Position Within the Biotechnology Landscape
Compared with drug-development peers, Treace Medical Concepts trades more like a product-adoption story, where reimbursement, procedure volume, and refresh cycles matter more than a single clinical binary.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System
Source: Treace Medical Concepts
- 02
Treace to Present at the Sidoti Small Cap Conference
Source: Treace Medical Concepts
- 03
Treace Medical Concepts Reports First Quarter 2026 Financial Results
Source: Treace Medical Concepts
- 04
Treace Announces Participation in Two Upcoming Investor Conferences
Source: Treace Medical Concepts
- 05
Treace Medical Secures Up to $175 Million in Debt Financing
Source: Treace Medical Concepts
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Treace Medical Concepts (TMCI)?
Treace Medical Concepts (TMCI) most recently closed at 4.49 USD, a +11.97% move versus the previous session.
What is the market cap of Treace Medical Concepts (TMCI)?
Treace Medical Concepts currently has a market capitalization of 291.28M USD on BioPharmSignal.
What does Treace Medical Concepts do?
Treace Medical Concepts is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
On which exchange is TMCI stock listed?
Treace Medical Concepts (TMCI) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Treace Medical Concepts is followed within the medical devices universe for its exposure to procedure trends and reimbursement support., Biotechnology.
What is Treace?
Treace Medical Concepts is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
Which conditions is Treace Medical Concepts targeting with Treace?
Treace Medical Concepts is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
What is Medical?
Treace Medical Concepts is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.
What is Concepts?
Treace Medical Concepts is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.